Galmed Pharmaceuticals (GLMD) Short-term Investments (2015 - 2025)

Galmed Pharmaceuticals' Short-term Investments history runs 11 years deep, the most recent figure standing at $124000.0 for Q4 2025.

• In Q4 2025, Short-term Investments fell 96.45% year-over-year to $124000.0; the TTM figure through Dec 2025 stood at $124000.0 (down 96.45% YoY), while the FY2025 annual figure was $124000.0, down 96.45% from the prior year.
• Short-term Investments was $124000.0 for Q4 2025 at Galmed Pharmaceuticals, up from -$1.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $31.9 million in Q4 2021 to a low of -$3.3 million in Q3 2024.
• Historically, Short-term Investments has averaged $1.4 million across 5 years, with a median of $114000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments jumped 1876.32% in 2023, then slumped 2994.78% in 2024.
• A 5-year view of Short-term Investments shows it stood at $31.9 million in 2021, then tumbled by 99.64% to $114000.0 in 2022, then surged by 1876.32% to $2.3 million in 2023, then jumped by 55.17% to $3.5 million in 2024, then sank by 96.45% to $124000.0 in 2025.
• The last three Short-term Investments figures came in at $124000.0 (Q4 2025), -$1.7 million (Q3 2025), and -$1.7 million (Q2 2025), per Business Quant data.